Literature DB >> 2098118

[Nosocomial bacteremia caused by Acinetobacter].

S Moreno1, T Vicente, M Armas, J C Bernaldo de Quirós, M Rodríguez-Créixems, E Bouza.   

Abstract

Forty episodes of nosocomial Acinetobacter calcoaceticus bacteremia produced by the Anitratus type over a period of 4 years were analyzed and compared with a control group of 28 patients with bacteremia produced by gram negative bacilli. Although most of acinetobacter bacteremia were endemic an outbreak involving 12 cases were observed in an intensive care unit during the study period. Thirteen patients presented a transient bacteremia. When the site of origin of the infection could be established the respiratory system was the most commonly involved (5 cases). Polymicrobial bacteremia was present in 11 patients (27.5%). Gram-positive cocci were the most commonly associated microorganisms. Most of isolated Acinetobacter strains were resistant to cotrimoxazole, beta-lactams, and aminoglycosides but were uniformly sensitive to ciprofloxacin and imipenem. The overall mortality was 22.5%. As compared with the control group, Acinetobacter bacteremia occurred more frequently during the first week of hospitalization and involved patients with less severe underlying diseases in whom three or more potential risk factors were detected. The entering site of infection was commonly unknown and the antibiotic treatment was inappropriate in most of the cases of Acinetobacter bacteremia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2098118

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  1 in total

1.  Risk Factors and Predictors of Mortality in Critically ill Children with Extensively-Drug Resistant Acinetobacter baumannii Infection in a Pediatric Intensive Care Unit.

Authors:  Kapil Kapoor; Sumidha Jain; Mamta Jajoo; Swati Dublish; Vikas Dabas; Vikas Manchanda
Journal:  Iran J Pediatr       Date:  2014-09-11       Impact factor: 0.364

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.